RYMDX
Price
$139.76
Change
+$1.02 (+0.74%)
Updated
Sep 5 closing price
Net Assets
12M
RYVLX
Price
$642.46
Change
+$1.07 (+0.17%)
Updated
Sep 5 closing price
Net Assets
1.04B
Interact to see
Advertisement

RYMDX vs RYVLX

Header iconRYMDX vs RYVLX Comparison
Open Charts RYMDX vs RYVLXBanner chart's image
Rydex Mid-Cap 1.5x Strategy H
Price$139.76
Change+$1.02 (+0.74%)
VolumeN/A
Net Assets12M
Rydex NASDAQ-100® 2x Strategy A
Price$642.46
Change+$1.07 (+0.17%)
VolumeN/A
Net Assets1.04B
RYMDX vs RYVLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RYMDX vs. RYVLX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYMDX is a Buy and RYVLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYVLX has more cash in the bank: 1.04B vs. RYMDX (12M). RYMDX pays higher dividends than RYVLX: RYMDX (0.69) vs RYVLX (0.00). RYMDX was incepted earlier than RYVLX: RYMDX (24 years) vs RYVLX (21 years). RYVLX (1.87) and RYMDX (1.79) have similar cost to investors . RYVLX is a more actively managed with annual turnover of: 383.00 vs. RYMDX (94.00). RYMDX (2500) and RYVLX (2500) have matching initial minimum investment requirements. RYVLX annual gain was more profitable for investors over the last year : 32.50 vs. RYMDX (12.25). RYVLX return over 5 years is better than : 113.05 vs. RYMDX (70.34).
RYMDXRYVLXRYMDX / RYVLX
Total Expense Ratio1.681.7497%
Annual Report Gross Expense Ratio1.791.8796%
Fund Existence24 years21 years-
Gain YTD5.77516.69035%
Front LoadN/A5%-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets12M1.04B1%
Annual Yield % from dividends0.690.00-
Returns for 1 year12.2532.5038%
Returns for 3 years48.62168.7629%
Returns for 5 years70.34113.0562%
Returns for 10 years135.30796.7117%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FTRE11.631.12
+10.66%
Fortrea Holdings
CRSP54.862.12
+4.02%
CRISPR Therapeutics AG
AZO4219.41-13.55
-0.32%
AutoZone
HHS3.67-0.05
-1.48%
Harte Hanks
MGRM5.71-0.23
-3.87%
Monogram Orthopaedics